Valneva Revenue 2024

Valneva Revenue

197.33 M EUR

Valneva Dividend yield

Ticker

VLA.PA

ISIN

FR0004056851

WKN

A0MVJZ

In 2024, Valneva's sales reached 197.33 M EUR, a 28.38% difference from the 153.71 M EUR sales recorded in the previous year.

The Valneva Revenue history

YEARREVENUE (undefined EUR)GROSS MARGIN (%)
2029e571.179,25
2028e482.0510,96
2027e414.8912,74
2026e286.1818,46
2025e224.1823,57
2024e197.3326,78
2023153.7134,37
2022361.310,20
2021348.0947,65
2020110.3257,49
2019126.260,40
2018113.0460,68
2017105.2956,33
201694.0654,20
201578.3640,07
201436.9253,57
201330.4545,78
20123.43100,00
201110.2642,02
20104.8461,08
20093.145,54
20083.42113,98
20070.87125,29
20062.33142,46
20053.01129,86
20041.4157,70

Valneva Aktienanalyse

What does Valneva do?

Valneva SE is a biopharmaceutical company specializing in the development, production, and marketing of vaccines for humans and animals. The company was founded in 2013 through the merger of French biotech company Vivalis and Austrian biotech company Intercell. Valneva focuses on developing vaccines for infectious diseases with a significant global burden but limited commercial demand. They work closely with governments and international organizations to improve access to their vaccines in developing countries. Valneva also has a strong presence in the animal vaccine market, producing vaccines for diseases in livestock and pets. They have developed and marketed several vaccines, including Ixiaro for Japanese encephalitis and VLA15, a vaccine candidate for Lyme disease. Overall, Valneva is an international company with an impressive pipeline of vaccine candidates and a commitment to addressing global health needs. Valneva ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Valneva's Sales Figures

The sales figures of Valneva originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Valneva’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Valneva's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Valneva’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Valneva Stock

How much revenue did Valneva generate this year?

Valneva has achieved a revenue of 197.33 M EUR this year.

How much was the turnover of the company Valneva compared to the previous year?

The revenue of Valneva has increased by 28.38% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Valneva?

The revenue of Valneva is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Valneva measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Valneva so important for investors?

The revenue of Valneva is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Valneva pay?

Over the past 12 months, Valneva paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Valneva is expected to pay a dividend of 0 EUR.

What is the dividend yield of Valneva?

The current dividend yield of Valneva is .

When does Valneva pay dividends?

Valneva pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Valneva?

Valneva paid dividends every year for the past 0 years.

What is the dividend of Valneva?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Valneva located?

Valneva is assigned to the 'Health' sector.

Wann musste ich die Aktien von Valneva kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Valneva from 5/25/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 5/25/2024.

When did Valneva pay the last dividend?

The last dividend was paid out on 5/25/2024.

What was the dividend of Valneva in the year 2023?

In the year 2023, Valneva distributed 0 EUR as dividends.

In which currency does Valneva pay out the dividend?

The dividends of Valneva are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Valneva stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Valneva

Our stock analysis for Valneva Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Valneva Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.